GEOVAX LABS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period
GEOVAX LABS, INC. (GOVX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period of 1.60 thousand shares for the 6-month period ending 2026-06-30, per its S-1 filed 2026-09-17.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod · last filed 2026-09-17
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-12-31 was 65.67K shares, a 64.17% increase year-over-year.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-09-30 was 31.33K shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-06-30 was 69.67K shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for the quarter ending 2018-03-31 was 68.33K shares, a 40.68% decline year-over-year.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2024 was 961.00 shares, a 63.97% decline from fiscal 2023.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2023 was 2.67K shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2022 was 0.00 shares.
- GEOVAX LABS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures and expirations in period for fiscal 2021 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.60K shares S-1 · filed 2026-09-17 | |||
| 2025-12-31 | 0.00 shares S-1 · filed 2026-09-17 | |||
| 2024-12-31 | 961.00 shares 10-K · filed 2025-03-27 | |||
| 2023-12-31 | 2.67K shares 10-K · filed 2024-02-29 | |||
| 2022-12-31 | 0.00 shares 10-K · filed 2023-03-23 | |||
| 2021-12-31 | 0.00 shares 10-K · filed 2022-03-09 | |||
| 2018-12-31 | 65.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-26 | 97.00K shares derived: sum of 2 quarters · filed 2019-03-26 | 166.67K shares derived: sum of 3 quarters · filed 2019-03-26 | 235.00K shares 10-K · filed 2019-03-26 |
| 2018-09-30 | 31.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | 101.00K shares derived: sum of 2 quarters · filed 2018-11-08 | 169.33K shares 10-Q · filed 2018-11-08 | 209.33K shares derived: sum of 4 quarters · filed 2018-11-08 |
| 2018-06-30 | 69.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | 138.00K shares 10-Q · filed 2018-08-07 | 178.00K shares derived: sum of 3 quarters · filed 2018-08-07 | 178.00K shares derived: sum of 4 quarters · filed 2018-08-07 |
| 2018-03-31 | 68.33K shares 10-Q · filed 2018-05-03 | 108.33K shares derived: sum of 2 quarters · filed 2018-05-03 | 108.33K shares derived: sum of 3 quarters · filed 2018-05-03 | 108.33K shares derived: sum of 4 quarters · filed 2018-05-03 |
| 2017-12-31 | 40.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-23 | 40.00K shares derived: sum of 2 quarters · filed 2018-03-23 | 40.00K shares derived: sum of 3 quarters · filed 2018-03-23 | 155.20K shares 10-K · filed 2018-03-23 |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-09 | 115.20K shares 10-Q · filed 2017-11-09 | |
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | 115.20K shares 10-Q · filed 2017-08-14 | ||
| 2017-03-31 | 115.20K shares 10-Q · filed 2017-05-12 | |||
| 2015-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-16 | 36.00K shares derived: sum of 2 quarters · filed 2016-03-16 | 36.00K shares derived: sum of 3 quarters · filed 2016-03-16 | 68.00K shares 10-K · filed 2016-03-16 |
| 2015-09-30 | 36.00K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | 36.00K shares derived: sum of 2 quarters · filed 2015-11-12 | 68.00K shares 10-Q · filed 2015-11-12 | 68.00K shares derived: sum of 4 quarters · filed 2015-11-12 |
| 2015-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | 32.00K shares 10-Q · filed 2015-08-04 | 32.00K shares derived: sum of 3 quarters · filed 2015-08-04 | 40.20K shares derived: sum of 4 quarters · filed 2015-08-04 |
| 2015-03-31 | 32.00K shares 10-Q · filed 2015-05-14 | 32.00K shares derived: sum of 2 quarters · filed 2015-05-14 | 40.20K shares derived: sum of 3 quarters · filed 2015-05-14 | 61.70K shares derived: sum of 4 quarters · filed 2015-05-14 |
| 2014-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-20 | 8.20K shares derived: sum of 2 quarters · filed 2015-03-20 | 29.70K shares derived: sum of 3 quarters · filed 2015-03-20 | 231.44K shares 10-K · filed 2015-03-20 |
| 2014-09-30 | 8.20K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | 29.70K shares derived: sum of 2 quarters · filed 2014-11-12 | 231.44K shares 10-Q · filed 2014-11-12 | 235.11K shares derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | 21.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | 223.25K shares 10-Q · filed 2014-08-08 | 226.91K shares derived: sum of 3 quarters · filed 2014-08-08 | 246.24K shares derived: sum of 4 quarters · filed 2014-08-08 |
| 2014-03-31 | 201.74K shares 10-Q · filed 2014-05-02 | 205.41K shares derived: sum of 2 quarters · filed 2014-05-02 | 224.74K shares derived: sum of 3 quarters · filed 2014-05-02 | 268.84K shares derived: sum of 4 quarters · filed 2014-05-02 |
| 2013-12-31 | 3.67K shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-14 | 23.00K shares derived: sum of 2 quarters · filed 2014-03-14 | 67.10K shares derived: sum of 3 quarters · filed 2014-03-14 | 82.10K shares 10-K · filed 2014-03-14 |
| 2013-09-30 | 19.33K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | 63.43K shares derived: sum of 2 quarters · filed 2013-11-12 | 78.43K shares 10-Q · filed 2013-11-12 | 256.63K shares derived: sum of 4 quarters · filed 2013-11-12 |
| 2013-06-30 | 44.10K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | 59.10K shares 10-Q · filed 2013-08-12 | 237.30K shares derived: sum of 3 quarters · filed 2013-08-12 | 175.90K shares derived: sum of 4 quarters · filed 2013-08-12 |
| 2013-03-31 | 15.00K shares 10-Q · filed 2013-05-01 | 193.20K shares derived: sum of 2 quarters · filed 2013-05-01 | 131.80K shares derived: sum of 3 quarters · filed 2013-05-01 | |
| 2012-12-31 | 178.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | 116.80K shares derived: sum of 2 quarters · filed 2013-03-18 | 97.60K shares 10-K · filed 2013-03-18 | |
| 2012-09-30 | -61.40K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-13 | -80.60K shares 10-Q · filed 2012-11-13 | ||
| 2012-06-30 | -19.20K shares 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B |